Spherix Announces Settlement Agreement, Continued Monetization of Patent Portfolio
Nov 19, 2013
"Following" : "Follow"}}
November 19, 2013 6:22am Comments
Spherix Incorporated (NASDAQ: SPEX ) --  announced today that its wholly owned subsidiary, CompuFill LLC, has entered into a settlement and license agreement with a leading technology company. This is the first settlement and license agreement for the CompuFill portfolio since Spherix acquired North South Holdings Inc. in September of 2013. Ongoing infringement enforcement continues as Spherix's model of patent monetization grows in both scope and size. The CompuFill patents, each in the "on-line pharmacy automated refill system" sector, trace priority back to October 1997. Commenting on the announcement, Anthony Hayes, Spherix CEO, stated, "The value of having this suite of patents cannot be emphasized enough. Our team of patent monetization experts brought this opportunity to Spherix only a few short months ago and we have already started generating revenue. This is a great example of how Spherix continues working to drive value for our investors. "
Spherix Incorporated was launched in 1967 as a scientific research company. Spherix presently offers a diversified commercialization platform for protected technologies. The company continues to work on life sciences and drug development and presently is exploring opportunities in nutritional supplement products